A ROS-Responsive Self-Assembly Driven by Multiple Intermolecular Interaction Enhances Tumor-Targeted Chemotherapy.

Journal of Pharmaceutical Sciences
Yongfu XiongJingdong Li

Abstract

To develop a drug carrier sensitive to reactive oxygen species (ROS), a nanocomplex (NCs) based on sulfuric hyaluronic acid (sHA)-anthocyanin (ATC) was developed. Doxorubicin (DOX) is loaded into the sHA-ATC NCs (AD@sHA) through intermolecular π-π stacking and hydrophobic interactions. AD@sHA can be prepared in aqueous phase by simple mixing method. In AD@sHA, DOX content and load efficiency are high. Compared with D@sHA (without ATC), the ROS-ATC co-mediated responsive degradation and drug release of AD@sHA was confirmed. In addition, AD@sHA also improved apoptosis of CD44+ colon cancer HT29 cells. HT29 tumor-bearing mice model was used to confirm the role of AD@SHA in targeted tumor therapy. The results showed that AD@SHA could optimize the biodistribution of DOX. These data, from tumor volume and TUNEL analysis, observed the delay of tumor growth and apoptosis of cancer cells. Even more exciting is that AD@sHA significantly reduces the myelosuppression of DOX. This study means that AD@sHA has a better effect on chemotherapy for CD44-positive tumors.

References

Aug 5, 2000·Journal of Natural Products·P G Pietta
Nov 6, 2012·Ageing Research Reviews·Venus SosaMatilde E LLeonart
Sep 16, 2015·Cell Communication and Signaling : CCS·Claudia LennickeBarbara Seliger
Oct 11, 2015·Journal of Drug Targeting·George MattheolabakisMansoor M Amiji
Dec 22, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dooyong JeongKun Na
Mar 31, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Muhammad Azizan SamadJamilah Syafawati Yaacob
May 4, 2016·Advanced Drug Delivery Reviews·Jennifer I HareSimon T Barry
Oct 27, 2016·British Journal of Pharmacology·Bo-Wen LinYing-Yu Cui
Mar 8, 2017·Seminars in Cancer Biology·Veronica HuberLicia Rivoltini
Oct 5, 2017·Nutrients·Yoon-Mi LeeKyung-Jin Yeum
Apr 6, 2018·Journal of Colloid and Interface Science·Samira Jafarzadeh-HolaghEbrahim Vasheghani-Farahani
Nov 13, 2018·Advanced Drug Delivery Reviews·Pooya DavoodiChi-Hwa Wang
Nov 30, 2018·Expert Opinion on Drug Delivery·Thomas VangijzegemSophie Laurent
Dec 11, 2019·International Journal of Nanomedicine·Zhi-Peng LiJing-Liang Wu
Mar 1, 2018·Asian Journal of Pharmaceutical Sciences·Wenhui Tao, Zhonggui He

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis